| Financial Year |
March 31 2023 |
| Monetary Funds |
81,011,956.45 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
305,904,104.21 |
| Advances to Suppliers |
7,118,042.67 |
| Other Receivables |
9,370,452.56 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
452,187,706.88 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,428,374.93 |
| Total Current Assets |
892,276,041.19 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
900,666.33 |
| Investment Properties |
1,698,834.05 |
| Fixed Assetes |
773,931,691.66 |
| Under-construction Projects |
147,822,731.38 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
270,395,141.31 |
| R&D expenses |
-- |
| Goodwill |
181,375,118.75 |
| Long-Term Deferred and Prepaid Expenses |
27,651,829.97 |
| Deferred Income Tax Assets |
1,057,779.22 |
| Other Non-Current Assets |
18,464,681.42 |
| Sub-Total of Non-Current Assets |
1,446,550,135.68 |
| Total Assets |
2,338,826,176.87 |
| Short-Term Loans |
324,741,104.07 |
| Trading Financial liabilities |
-- |
| Notes Payable |
89,404,500.00 |
| Accounts Payable |
259,450,600.75 |
| Accounts Received In Advance |
180,705.00 |
| Employee Compensation Payable |
42,140,991.46 |
| Taxes Payable |
9,147,851.79 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,645,025.82 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,034,444.37 |
| Other Current Liabilities |
299,209.78 |
| Sub-Total of Current Liabilities |
751,307,629.73 |
| Long-term Loans |
135,995,416.90 |
| Bonds Payable |
155,947,745.98 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,577,399.79 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
346,913,597.23 |
| Total Liabilities |
1,098,221,226.96 |
| Paid-In Capital(Or Share Stock) |
222,501,003.00 |
| Capital Surplus |
371,486,058.66 |
| Surplus Reserve |
64,533,886.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
422,347,403.08 |
| Minority Stockholder's Interest |
144,542,434.16 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,096,062,515.75 |
| Owner's Equity（Stockholder's Equity） |
1,240,604,949.91 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,338,826,176.87 |
